You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug CURIST MUCUS RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for CURIST MUCUS RELIEF

Last updated: March 3, 2026

What are the key excipient considerations for CURIST MUCUS RELIEF?

Excipient formulation impacts drug stability, bioavailability, patient compliance, and manufacturing efficiency. For CURIST MUCUS RELIEF, an over-the-counter (OTC) respiratory solution, the excipient strategy should optimize efficacy and shelf life while ensuring safety and ease of use.

Core excipients involved:

  • Vehicle or carrier liquids: Water as solvent; may include purified water with preservatives
  • Preservatives: Benzalkonium chloride, methylparaben, or phenoxyethanol to prevent microbial growth
  • Sweeteners: Sorbitol, sucralose to improve taste
  • Flavoring agents: Menthol, eucalyptus oil for local soothing effect
  • pH buffers: Citric acid or sodium citrate to maintain stability
  • Emulsifiers or suspending agents (if needed): Glycerin, xanthum gum for suspension consistency

Formulation challenges:

  • Ensuring stability of active ingredients in aqueous media
  • Avoiding excipient interactions that could degrade efficacy
  • Maintaining compatibility with packaging materials

How does excipient selection influence manufacturing and cost?

Selecting excipients with high purity, low variability, and compatibility reduces manufacturing risks. For OTC products, excipients contribute significantly to production costs. Using cost-effective, approved excipients like purified water and common flavoring agents helps keep retail prices competitive.

What are the regulatory considerations for excipient use?

  • Compliance with OTC monographs and regulatory agencies (FDA, EMA)
  • Clear labeling of excipients known to cause allergies (e.g., preservatives)
  • Documentation of excipient approval status and batch consistency

What commercial opportunities exist with excipient innovation?

Novel excipient applications:

  • Taste-masking technologies: Using advanced sweeteners or flavor carriers to appeal to children and adults
  • Improved preservative systems: Development of preservative-free or natural preservative systems to meet clean-label trends
  • Extended shelf life: Use of stabilization agents that extend expiration timelines

Market differentiation:

  • Unique excipient combinations that improve flavor, texture, or stability
  • Formulations suited for specific demographics (e.g., pediatric or geriatric populations)
  • Compatibility with innovative delivery systems like oral sprays or dissolvable strips

Supply chain and sustainability:

  • Sourcing plant-based or organic excipients appeals to health-conscious consumers
  • Developing formulations with excipients that support sustainability profiles

What are the key market drivers and barriers?

Drivers Barriers
Increasing demand for OTC respiratory remedies Stringent regulatory approval for new excipients
Consumer preference for natural and preservative-free products Cost increase for high-quality, novel excipients
Technological advances in flavoring and stabilization Patent and regulatory uncertainties

Summary of commercial opportunities:

  • Developing clean-label, preservative-free formulations
  • Innovating taste-masking and sensory experience
  • Enhancing stability for extended shelf life
  • Customizing formulations for targeted demographics
  • Investing in sustainable excipient sourcing

Key Takeaways

  • Excipient selection for CURIST MUCUS RELIEF directly impacts product stability, safety, and consumer appeal.
  • Market differentiation can be achieved through innovative excipient choice, such as natural preservatives or taste-masking agents.
  • Cost management through strategic excipient sourcing influences profitability.
  • Regulatory compliance is critical; excipients must meet strict safety standards for OTC products.
  • Growth opportunities exist in formulations optimizing natural ingredients, extended shelf life, and tailored delivery systems.

FAQs

1. How can excipient innovation improve patient compliance?
By enhancing flavor, reducing irritation, and ensuring stability, excipients contribute to a more pleasant user experience, encouraging sustained use.

2. What trends are shaping excipient choices for OTC respiratory products?
Natural ingredients, preservative-free formulations, and sustainability are pushing excipient innovation. Also, formulations that extend shelf life without synthetic preservatives are in demand.

3. Are there regulatory limits on novel excipients in OTC drugs?
Yes. They must be approved by agencies like the FDA or EMA. Extensive safety testing and documentation are required before market entry.

4. Can excipients influence patent protection?
Yes. Unique excipient combinations or formulations may be patentable, providing a competitive edge.

5. What cost considerations should be balanced with excipient innovation?
While novel excipients may add to costs, their benefits in market positioning and consumer acceptance can outweigh expenses. Cost-benefit analysis should guide formulation choices.


References

  1. U.S. Food and Drug Administration (FDA). (2022). Over-the-counter drug products. Retrieved from https://www.fda.gov/drugs/buying-using-medicine-safely/over-counter-drug-products
  2. European Medicines Agency (EMA). (2021). Guideline on excipients in the label and package leaflet of medicines for human use. Retrieved from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-excipients-label-package-leaflet-medicines-human-use_en.pdf
  3. Andrews, J., & Brown, R. (2020). Excipient considerations in OTC formulations. Pharmaceutical Technology. 44(3): 52-58.
  4. Smith, L. (2021). Natural excipients in respiratory drug formulations. International Journal of Pharmaceutical Sciences. 13(2): 100-109.
  5. Lee, K., et al. (2019). Advances in taste-masking for OTC medicines. Drug Development and Industrial Pharmacy. 45(12): 1884-1892.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.